Orthobiologics Market by Product (Demineralized Bone Matrix {DBM}, Allograft, Bone Morphogenetic Protein {BPM}, Viscosupplementation Products, Synthetic Bone Substitutes and Others), Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture recovery, Soft Tissue Injuries, and Maxillofacial & Dental Applications), Type (Knee, Ankle, Hip, Wrist & shoulder, Spine, and Others), and End User (Hospitals & Ambulatory Centers, Research & Academic Institute, and Dental Clinics): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3416
- Pages: 283
-
Format:
The global orthobiologics market was valued at $4,870 million in 2017 and is projected to reach $6,870 million by 2025, registering a CAGR of 4.3% from 2018 to 2025.
Orthobiologics are substances, found in human body, used for faster healing process of injuries, such as broken bones, injured muscles, and ligaments. These substances are made up of substances found in human body. When orthobiologics are used in higher concentration, they help accelerate healing process and thus reduce the number of hospital visits.
Increase in demand for advanced treatment, rise in prevalence of osteoarthritis, degenerative arthritis, spinal injuries, and soft tissue injuries boost the growth of the orthobiologics market In addition, rise in road accidents & sports injuries, surge in obesity rate, awareness among patients, and rapidly aging population drive the growth of the global orthobiologics market. However, high cost of procedures, and stringent regulatory approval procedures restrain the growth of this market. Advancements in implant technologies and rise in demand for biological solutions as compared to mechanical solutions create opportunities for the growth of the market.
The global orthobiologics market is segmented based on product, application, type, end user, and region. Based on product, the market is classified into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), Viscosupplementation products, synthetic bone substitutes, and others. Based on type, the market is categorized into knee, ankle, hip, wrist & shoulder, spine, and others. Based on end user, the market is divided into hospitals & ambulatory centers, research & academic institute, and dental clinics. Based on application, the market is further fragmented into osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial & dental applications.
Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
By Type
Knee
Ankle
Hip
Wrist & Shoulder
Spine
Others
By Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial & Dental Applications
By End User
Hospitals & Ambulatory Centers
Research & Academic Institute
Dental Clinics
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o India
o China
o Japan
o Australia
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Arthrex, Inc. (Arthrex)
Exactec Inc.
Globus Medical, Inc.
Integra LifeSciences Holdings Corporation
Johnson and Johnson (J&J)
Medline Industries, Inc.
NuVasive Inc.
Stryker Corporation
Wright Medical Group, Inc.
Zimmer Biomet Holdings, Inc.,
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
Kuros Biosciences AG
XTANT MEDICAL
Bioventus
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.5. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Porters five forces analysis
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Rise in incidence of orthopedic diseases & injury
3.3.1.2. Growth in aging population
3.3.1.3. Increase in sports injuries
3.3.2. Restraints
3.3.2.1. High cost of orthobiologics product
3.3.2.2. Stringent approval process
3.3.3. Opportunity
3.3.3.1. Improvement in healthcare infrastructure
3.4. Top player positioning, 2017
Chapter: 4: ORTHOBIOLOGICS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Demineralized bone matrix (DBM)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Allograft
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Bone morphogenetic protein (BPM)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Viscosupplementation products
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Synthetic bone substitutes
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
Chapter: 5: ORTHOBIOLOGICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Osteoarthritis & degenerative arthritis
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Spinal fusion
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Fracture recovery
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Soft tissue injuries
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Maxillofacial & dental applications
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
Chapter: 6: ORTHOBIOLOGICS MARKET, BY TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Knee
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Ankle
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Hip
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Wrist & shoulder
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Spine
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
6.7. Others
6.7.1. Market size and forecast
6.7.2. Market analysis, by country
Chapter: 7: ORTHOBIOLOGICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals & ambulatory centers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Research & academic institute
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Dental clinics
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
Chapter: 8: GLOBAL ORTHOBIOLOGICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends and opportunities
8.2.1.1. US
8.2.1.1.1. Market size and forecast, by product type
8.2.1.1.2. Market size and forecast, by application
8.2.1.1.3. Market size and forecast, by type
8.2.1.1.4. Market size and forecast, by end user
8.2.1.2. Canada
8.2.1.2.1. Market size and forecast, by product type
8.2.1.2.2. Market size and forecast, by application
8.2.1.2.3. Market size and forecast, by type
8.2.1.2.4. Market size and forecast, by end user
8.2.1.3. Mexico
8.2.1.3.1. Market size and forecast, by product type
8.2.1.3.2. Market size and forecast, by application
8.2.1.3.3. Market size and forecast, by type
8.2.1.3.4. Market size and forecast, by end user
8.2.2. North America Orthobiologics Market size and forecast, by product type
8.2.3. North America Orthobiologics Market size and forecast, by application
8.2.4. North America Orthobiologics Market size and forecast, by type
8.2.5. North America Orthobiologics Market size and forecast, by end user
8.2.6. North America Orthobiologics Market size and forecast, by region
8.3. Europe
8.3.1. Key market trends and opportunities
8.3.1.1. Germany
8.3.1.1.1. Market size and forecast, by product type
8.3.1.1.2. Market size and forecast, by application
8.3.1.1.3. Market size and forecast, by type
8.3.1.1.4. Market size and forecast, by end user
8.3.1.2. France
8.3.1.2.1. Market size and forecast, by product type
8.3.1.2.2. Market size and forecast, by application
8.3.1.2.3. Market size and forecast, by type
8.3.1.2.4. Market size and forecast, by end user
8.3.1.3. UK
8.3.1.3.1. Market size and forecast, by product type
8.3.1.3.2. Market size and forecast, by application
8.3.1.3.3. Market size and forecast, by type
8.3.1.3.4. Market size and forecast, by end user
8.3.1.4. Italy
8.3.1.4.1. Market size and forecast, by product type
8.3.1.4.2. Market size and forecast, by application
8.3.1.4.3. Market size and forecast, by type
8.3.1.4.4. Market size and forecast, by end user
8.3.1.5. Spain
8.3.1.5.1. Market size and forecast, by product type
8.3.1.5.2. Market size and forecast, by application
8.3.1.5.3. Market size and forecast, by type
8.3.1.5.4. Market size and forecast, by end user
8.3.1.6. Rest of Europe
8.3.1.6.1. Market size and forecast, by product type
8.3.1.6.2. Market size and forecast, by application
8.3.1.6.3. Market size and forecast, by type
8.3.1.6.4. Market size and forecast, by end user
8.3.2. Europe Orthobiologics Market size and forecast, by product type
8.3.3. Europe Orthobiologics Market size and forecast, by application
8.3.4. Europe Orthobiologics Market size and forecast, by type
8.3.5. Europe Orthobiologics Market size and forecast, by end user
8.3.6. Europe Orthobiologics Market size and forecast, by region
8.4. Asia-Pacific
8.4.1. Key market trends and opportunities
8.4.1.1. Japan
8.4.1.1.1. Market size and forecast, by product type
8.4.1.1.2. Market size and forecast, by application
8.4.1.1.3. Market size and forecast, by type
8.4.1.1.4. Market size and forecast, by end user
8.4.1.2. China
8.4.1.2.1. Market size and forecast, by product type
8.4.1.2.2. Market size and forecast, by application
8.4.1.2.3. Market size and forecast, by type
8.4.1.2.4. Market size and forecast, by end user
8.4.1.3. Australia
8.4.1.3.1. Market size and forecast, by product type
8.4.1.3.2. Market size and forecast, by application
8.4.1.3.3. Market size and forecast, by type
8.4.1.3.4. Market size and forecast, by end user
8.4.1.4. India
8.4.1.4.1. Market size and forecast, by product type
8.4.1.4.2. Market size and forecast, by application
8.4.1.4.3. Market size and forecast, by type
8.4.1.4.4. Market size and forecast, by end user
8.4.1.5. South Korea
8.4.1.5.1. Market size and forecast, by product type
8.4.1.5.2. Market size and forecast, by application
8.4.1.5.3. Market size and forecast, by type
8.4.1.5.4. Market size and forecast, by end user
8.4.1.6. Rest of Asia-Pacific
8.4.1.6.1. Market size and forecast, by product type
8.4.1.6.2. Market size and forecast, by application
8.4.1.6.3. Market size and forecast, by type
8.4.1.6.4. Market size and forecast, by end user
8.4.2. Asia-Pacific Orthobiologics Market size and forecast, by product type
8.4.3. Asia-Pacific Orthobiologics Market size and forecast, by application
8.4.4. Asia-Pacific Orthobiologics Market size and forecast, by type
8.4.5. Asia-Pacific Orthobiologics Market size and forecast, by end user
8.4.6. Asia-Pacific Orthobiologics Market size and forecast, by region
8.5. LAMEA
8.5.1. Key market trends and opportunities
8.5.1.1. Brazil
8.5.1.1.1. Market size and forecast, by product type
8.5.1.1.2. Market size and forecast, by application
8.5.1.1.3. Market size and forecast, by type
8.5.1.1.4. Market size and forecast, by end user
8.5.1.2. Saudi Arabia
8.5.1.2.1. Market size and forecast, by product type
8.5.1.2.2. Market size and forecast, by application
8.5.1.2.3. Market size and forecast, by type
8.5.1.2.4. Market size and forecast, by end user
8.5.1.3. South Africa
8.5.1.3.1. Market size and forecast, by product type
8.5.1.3.2. Market size and forecast, by application
8.5.1.3.3. Market size and forecast, by type
8.5.1.3.4. Market size and forecast, by end user
8.5.1.4. Rest of LAMEA
8.5.1.4.1. Market size and forecast, by product type
8.5.1.4.2. Market size and forecast, by application
8.5.1.4.3. Market size and forecast, by type
8.5.1.4.4. Market size and forecast, by end user
8.5.2. LAMEA Orthobiologics Market size and forecast, by product type
8.5.3. LAMEA Orthobiologics Market size and forecast, by application
8.5.4. LAMEA Orthobiologics Market size and forecast, by type
8.5.5. LAMEA Orthobiologics Market size and forecast, by end user
8.5.6. LAMEA Orthobiologics Market size and forecast, by region
Chapter: 9: COMPANY PROFILES
9.1. ARTHREX, INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. EXACTECH, INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. GLOBUS MEDICAL INC.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES INC.)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.5. JOHNSON & JOHNSON (DEPUY SYNTHES)
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. MEDLINE INDUSTRIES, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating product segments
9.6.4. Product Portfolio
9.7. NUVASIVE INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. STRYKER CORPORATION
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. WRIGHT MEDICAL GROUP, INC.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. ZIMMER BIOMET HOLDINGS, INC
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
